Home  |  Corporate Info  |  R & D  |  Products  |  Investor Relations  |  For the Patient  |  Careers at Hemispherx  


 

Officers & Directors

Board of Directors: Executive Officers:
William A. Carter, M.D.
Chairman of the Board, President, 
Chief Executive Officer
Ransom W. Ethridge
Director 
Iraj E. Kiani, N. D., Ph.D.
Director
William M. Mitchell, M.D.
Director
Richard C. Piani
Director

 
William A. Carter, M.D.
Chairman of the Board, Chief Executive Officer
Anthony Bonelli
President & Chief Operating Officer
Robert E. Peterson
Chief Financial Officer
David R. Strayer, M.D.
Medical Director - Regulatory Affairs
Carol A. Smith, Ph.D. 
Vice President, Manufacturing Quality Assurance and Process Development
 


    
Information contained on the Hemispherx website other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risks of competition, changing market conditions, changes in laws and regulations affecting these industries and numerous other factors discussed on the Hemispherx website and in the Company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements. Additionally, all the referenced investigational drugs and associated technologies of the company are experimental in nature and as such are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials with the referenced disorders. The forward-looking statements represent the Company's judgment as of the date of this website. The Company disclaims, however, any intent or obligation to update these forward-looking statements.